Chicago Growth Partners logo

Chicago Growth Partners

North America, Illinois, United States, Chicago

Description

Chicago Growth Partners (CGP) is a Midwest US based private equity firm that provides expansion and buyout capital to middle-market

Investor Profile

Chicago Growth Partners has made 15 investments, with 0 in the past 12 months and 20% as lead.

Stage Focus

  • Series Unknown (40%)
  • Series E (13%)
  • Series I (7%)
  • Series F (7%)
  • Debt Financing (7%)
  • Series B (7%)
  • Series D (7%)
  • Series G (7%)
  • Series A (7%)

Country Focus

  • United States (100%)

Industry Focus

  • Health Care
  • Medical Device
  • Health Diagnostics
  • Biotechnology
  • Pharmaceutical
  • Advanced Materials
  • Electronics
  • Oncology
  • Medical
  • Advertising
circle-line
FAQ

Frequently Asked Questions

Learn who this investor regularly partners with—both firms and angels—and explore their latest activity.

Who does Chicago Growth Partners frequently co-invest with?

Abingworth
Europe, England, United Kingdom, London
Co-Investments: 1
Oakwood Medical Investors
North America, Missouri, United States, St Louis
Co-Investments: 5
DeNovo Ventures
North America, California, United States, Saratoga
Co-Investments: 7
Canaan Partners
North America, California, United States, Menlo Park
Co-Investments: 6
CRG
North America, Texas, United States, Houston
Co-Investments: 2
Radius Ventures
North America, New York, United States, New York
Co-Investments: 6
MPM Capital
North America, Massachusetts, United States, Boston
Co-Investments: 4
Advanced Technology Ventures
North America, California, United States, Menlo Park
Co-Investments: 9
FM
North America, Connecticut, United States, Norwalk
Co-Investments: 8
Clarus Ventures
North America, Massachusetts, United States, Cambridge
Co-Investments: 1

What are some of recent deals done by Chicago Growth Partners?

EndoGastric Solutions

San Mateo, California, United States

EGS manufactures EsophyX technology is used to reconstruct the gastroesophageal valve in the TIF 2.0 procedure.

Health CareHealth DiagnosticsMedical Device
Series IJun 19, 2018
Amount Raised: $40,648,790
EndoGastric Solutions

San Mateo, California, United States

EGS manufactures EsophyX technology is used to reconstruct the gastroesophageal valve in the TIF 2.0 procedure.

Health CareHealth DiagnosticsMedical Device
Series UnknownDec 1, 2015
Amount Raised: $50,000,000
2Checkout

Columbus, Ohio, United States

2Checkout is the leading all-in-one monetization platform for global businesses.

BillingE-CommerceMobile PaymentsPayments
Series AJul 16, 2014
Amount Raised: $60,000,000
Medical Scribe Systems

Fort Lauderdale, Florida, United States

A medical scribe company committed to improving providers and patients lives

Health CareMedical
Debt FinancingJul 1, 2014
EndoGastric Solutions

San Mateo, California, United States

EGS manufactures EsophyX technology is used to reconstruct the gastroesophageal valve in the TIF 2.0 procedure.

Health CareHealth DiagnosticsMedical Device
Series GMay 6, 2014
Amount Raised: $30,000,000
EndoGastric Solutions

San Mateo, California, United States

EGS manufactures EsophyX technology is used to reconstruct the gastroesophageal valve in the TIF 2.0 procedure.

Health CareHealth DiagnosticsMedical Device
Series UnknownJun 21, 2012
Amount Raised: $13,000,000
EndoGastric Solutions

San Mateo, California, United States

EGS manufactures EsophyX technology is used to reconstruct the gastroesophageal valve in the TIF 2.0 procedure.

Health CareHealth DiagnosticsMedical Device
Series UnknownApr 1, 2012
Amount Raised: $2,109,800
EndoGastric Solutions

San Mateo, California, United States

EGS manufactures EsophyX technology is used to reconstruct the gastroesophageal valve in the TIF 2.0 procedure.

Health CareHealth DiagnosticsMedical Device
Series FAug 30, 2010
Amount Raised: $30,000,000
Zogenix

San Diego, California, United States

Zogenix develops and commercializes products for the treatment of central nervous system disorders and pain.

BiotechnologyHealth CarePharmaceutical
Series UnknownJul 13, 2010
Amount Raised: $15,000,000
EndoGastric Solutions

San Mateo, California, United States

EGS manufactures EsophyX technology is used to reconstruct the gastroesophageal valve in the TIF 2.0 procedure.

Health CareHealth DiagnosticsMedical Device
Series ENov 30, 2009
Amount Raised: $21,500,000